Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.89
+1.15 (10.71%)
Jan 28, 2026, 12:24 PM EST - Market open
Korro Bio Revenue
Korro Bio had revenue of $1.09M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $7.37M. In the year 2024, Korro Bio had annual revenue of $2.27M.
Revenue (ttm)
$7.37M
Revenue Growth
n/a
P/S Ratio
13.67
Revenue / Employee
$84,724
Employees
87
Market Cap
111.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.27M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKRRO News
- 8 days ago - Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Korro to Host Virtual Analyst Day on January 27, 2026 - GlobeNewsWire
- 20 days ago - Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Korro Bio Early Trial Results Fall Short; Stock Hits New Low - Benzinga
- 2 months ago - This biotech is halting its work with Novo Nordisk and laying off more people - Market Watch
- 2 months ago - Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs - GlobeNewsWire
- 5 months ago - Korro to Participate in Upcoming Investor and Scientific Conferences - GlobeNewsWire
- 6 months ago - Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire